OBJECTIVES: The first consensus report presented by the European Germ Cell Cancer
Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many …

To determine the optimal use of chemotherapy in the neoadjuvant, adjuvant, and metastatic
setting in patients with advanced urothelial cell carcinoma, a consensus conference was …

Advanced cancer is associated with emotional distress, especially depression and feelings
of sadness. To date, it is unclear which is the most effective way to address these problems …

PURPOSE: To test the equivalence of three versus four cycles of bleomycin, etoposide, and
cisplatin (BEP) and of the 5-day schedule versus 3 days per cycle in good-prognosis germ …

BACKGROUND: Because metastatic nonseminomatous germ cell cancer is a rare but
treatable cancer, we have explored whether there is an association between the experience …

Chimeric monoclonal antibody G250 (WX-G250) binds to a cell surface antigen found on>
90% of renal cell carcinoma (RCC). A multicentre phase II study was performed to evaluate …

Objective: To compare the efficacy and side effects of ondansetron with those of high-dose
metoclopramide in treating acute and delayed cisplatin-induced nausea and vomiting …

Renal cell carcinoma (RCC) is the most prevalent malignancy within the kidney and the
incidence is rising. Due to improved radiological evaluation over 50% of the renal cancers …

The cell‐cell adhesion molecule E‐cadherin has been shown to suppress invasive growth of
epithelial cells in vitro, and loss of its expression is thought to be important in invasion and …

Purpose: To describe global quality of life (GLQL) in pa-tients with metastatic testicular
cancer (TC) treated with four different schedules of bleomycin, etoposide, and cisplatin …